Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New treatment for rare cancer cholangiocarcinoma approved in Australia 2022-09-15 21:00
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance 2022-09-15 17:07
J INTS BIO, poster presentation of further preclinical data of its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' at the 2022 European Society for Medical Oncology Congress in Paris, France (ESMO 2022) 2022-09-15 14:12
United Imaging Announces Clinical System Installations at Huntsman Cancer Institute at the University of Utah 2022-09-14 21:00
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-09-14 20:30
DR CATHERINE MOHR TO JOIN BOARD OF MEDTECH COMPANY AROA BIOSURGERY 2022-09-14 13:05
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS 2022-09-14 11:09
New Study by Lunit and MGH Validates Effectiveness of AI as Aid in Chest X-Ray Interpretation - Published in JAMA Network Open 2022-09-13 22:16
EDGC (Eone Diagnomics Genome Center) recruits Sam Martin, Vice President of Overseas Business Development... to "accelerate entering the overseas market" 2022-09-13 21:00
I-Mab Announces Approval from China CDE to Initiate Phase 3 Registrational Study of Lemzoparlimab in Combination with Azacitidine in Higher-Risk Myelodysplastic Syndrome 2022-09-13 20:00
First and only TIGIT/TGF-β dual-targeting antibody fusion protein of Akeso demonstrated promise in preclinical results published at ESMO 2022-09-13 14:02
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test 2022-09-12 21:37
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022 2022-09-10 21:00
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development 2022-09-10 05:13
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers 2022-09-09 20:00
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company 2022-09-09 17:53
Antengene to Present at Upcoming Industry Conferences 2022-09-09 14:43
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting 2022-09-08 20:30
InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer 2022-09-08 08:00
Biosion, Inc. Appoints Dr. Rakesh Dixit, ADC Thought Leader, to Advisory Board 2022-09-07 20:54
1 112 113 114 115 116 432